SlidesetInternational Hepatitis Cure & Eradication Meeting 2015Perspective from Payers - Mel Krajden, MD, FRCPC & Bonnie Henry, MD, MPH, FRCPCView Slideset
SlidesetInternational Hepatitis Cure & Eradication Meeting 2015Perspective from Civil Society - Tracy SwanView Slideset
SlidesetInternational Hepatitis Cure & Eradication Meeting 2015Perspective from health economics - David Rein, PhDView Slideset
SlidesetInternational Hepatitis Cure & Eradication Meeting 2015Hepatitis C treatment in resource-limited countries - Gamal Esmat, MDView Slideset
JFJordan FeldMD, MPHSlidesetInternational Hepatitis Cure & Eradication Meeting 2015New Treatment in HCV: Is there need for more therapies? - Jordan Feld, MD, MPHView Slideset
SlidesetInternational Hepatitis Cure & Eradication Meeting 2015Maximizing SVR with current HCV therapy - Alnoor Ramji, MD, FRCPView Slideset
SLStephen LocarniniBSc(Hons), PhD, MBBS, FRC(Path)SlidesetInternational Hepatitis Cure & Eradication Meeting 2015New tools for testing and monitoring Hepatitis B and C - Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)View Slideset
HJHarry JanssenMD, PhDSlidesetInternational Hepatitis Cure & Eradication Meeting 2015New Treatment Strategies for Hepatitis B - Harry Janssen, MD, PhDView Slideset
JWJohn WardMDSlidesetInternational Hepatitis Cure & Eradication Meeting 2015Baby Boomer Screening in the U.S: Delivering on the promise thus far? - John Ward, MDView Slideset
SlidesetInternational Hepatitis Cure & Eradication Meeting 2015Hepatitis B Vaccine: Optimizing coverage and efficacy - Alex Vorsters, PhDView Slideset
SlidesetInternational Hepatitis Cure & Eradication Meeting 2015Point-of-care (POC) testing in Hepatitis B and C - Scott Bowden, PhDView Slideset
SlidesetInternational Hepatitis Cure & Eradication Meeting 2015A hepatitis C Vaccine: How do we prove it works? - Kimberly PageView Slideset
